Holen Sie sich die Stockscreener-App
14.39
6.83%
0.92
Handel nachbörslich:
14.45
0.06
+0.42%
Schlusskurs vom Vortag:
$13.47
Offen:
$13.55
24-Stunden-Volumen:
2.21M
Relative Volume:
1.06
Marktkapitalisierung:
$1.47B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-804.34M
KGV:
-1.5292
EPS:
-9.41
Netto-Cashflow:
$-531.06M
1W Leistung:
-4.45%
1M Leistung:
+3.30%
6M Leistung:
-65.57%
1J Leistung:
-63.39%
1-Tages-Spanne:
$13.44
$14.61
1-Wochen-Bereich:
$12.83
$15.29
52-Wochen-Spanne:
$12.79
$55.70
Biohaven Ltd Stock (BHVN) Company Profile
Firmenname
Biohaven Ltd
Sektor
Branche
Telefon
203-404-0410
Adresse
215 CHURCH STREET, NEW HAVEN, CT
Vergleichen Sie BHVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
14.39 | 1.38B | 0 | -804.34M | -531.06M | -9.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-19 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-09-16 | Eingeleitet | Jefferies | Buy |
| 2024-09-04 | Eingeleitet | Bernstein | Outperform |
| 2024-07-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2023-12-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-12-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-01-24 | Eingeleitet | SVB Securities | Outperform |
| 2023-01-04 | Eingeleitet | JP Morgan | Overweight |
| 2022-12-02 | Eingeleitet | BTIG Research | Buy |
| 2022-10-26 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-08-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-05-11 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-08-10 | Herabstufung | UBS | Buy → Neutral |
| 2021-08-03 | Bestätigt | Canaccord Genuity | Buy |
| 2021-03-11 | Eingeleitet | UBS | Buy |
| 2020-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-17 | Eingeleitet | Cowen | Outperform |
| 2020-02-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-02-06 | Eingeleitet | Mizuho | Buy |
| 2019-11-22 | Eingeleitet | Wedbush | Outperform |
| 2019-06-25 | Bestätigt | Canaccord Genuity | Buy |
| 2019-05-06 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | Bestätigt | Needham | Buy |
| 2018-07-03 | Bestätigt | Needham | Buy |
| 2018-07-02 | Bestätigt | Needham | Buy |
| 2018-04-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-02-22 | Bestätigt | Canaccord Genuity | Buy |
| 2017-12-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-10-03 | Bestätigt | Needham | Buy |
Alle ansehen
Biohaven Ltd Aktie (BHVN) Neueste Nachrichten
Deadline Alert: Biohaven Ltd. (BHVN) Investors Who Lost - GlobeNewswire
Deadline Alert: Biohaven Ltd. (BHVN) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
Pomerantz Law Firm Announces the Filing of a Class Action Against Biohaven Ltd. and Certain Officers – BHVN - FinancialContent
Biohaven price target lowered to $50 from $60 at Leerink - MSN
Biohaven (NYSE:BHVN) Given New $54.00 Price Target at Morgan Stanley - Defense World
Biohaven (NYSE:BHVN) Given New $52.00 Price Target at Robert W. Baird - Defense World
Biohaven (NYSE:BHVN) Given New $49.00 Price Target at Bank of America - Defense World
Securities Lawsuit Alert: Biohaven Ltd. (BHVN) InvestorsContact Levi & Korsinsky Before September 12, 2025 - ACCESS Newswire
Can Biohaven Ltd. reach all time highs this yearRisk Adjusted Portfolio Ideas - thegnnews.com
Biohaven price target lowered to $30 from $54 at H.C. Wainwright - MSN
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven - GlobeNewswire
Biohaven price target lowered to $49 from $50 at BofA - MSN
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. LawsuitBHVN - Morningstar
Biohaven Ltd: Navigating Market Fluctuations with a 1.37B Market Cap - investchronicle.com
Biohaven Pharmaceutical stock price target lowered to $30 at H.C. Wainwright - Investing.com India
Biohaven Pharmaceutical stock price target lowered to $30 at H.C. Wainwright By Investing.com - Investing.com South Africa
Biohaven Ltd. Breaks Losing Streak — Is the Trend ReversingEarly Breakout Entry Point Notifications Sent - 선데이타임즈
Biohaven Ltd. Sued for Securities Law Violations – - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges Investors in XPLR - GlobeNewswire
BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Lawsuit Alert: Investors who lost money with shares of Biohaven - openPR.com
Promising Developments and Regulatory Progress at Biohaven Ltd. Support Buy Rating - TipRanks
Biohaven Ltd. (BHVN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Biohaven’s Strategic Advances and Promising Data Drive Buy Rating - TipRanks
Pomerantz Law Firm Announces the Filing of a Class Action Against Biohaven Ltd. and Certain OfficersBHVN - PR Newswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Biohaven Ltd.(BHVN) Shareholders - PR Newswire
Biohaven reports second quarter 2025 financial results - MarketScreener
Biohaven reports higher than expected R&D expenses in Q2 By Investing.com - Investing.com South Africa
Biohaven reports higher than expected R&D expenses in Q2 - Investing.com India
Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments - PR Newswire
Levi & Korsinsky Notifies Biohaven Ltd. (BHVN) InvestorsLead Plaintiff Deadline on September 12, 2025 - ACCESS Newswire
BHVN Investors Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
BHVN Investors Have Opportunity to Lead Biohaven Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Visual analytics tools that track Biohaven Ltd. performancePredictive Short-Term Market Reversal Alerts - Newser
Candlestick signals on Biohaven Ltd. stock todayAI Screener for Daily Stock Forecast - Newser
BHVN ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Biohaven Ltd.September 12, 2025 Deadline - ACCESS Newswire
Biohaven Ltd. stock prediction for this weekPrice Action Trading with Volume Confirmation - Newser
Published on: 2025-08-09 04:28:36 - Newser
Biohaven Ltd. (NYSE:BHVN) Receives Average Rating of “Buy” from Brokerages - Defense World
Can Biohaven Ltd. recover in the next quarterFree Earnings Play Trade Plan With Alerts - Newser
Applying big data sentiment scoring on Biohaven Ltd.Investment Timeline and ROI Summary Report - Newser
Real time alert setup for Biohaven Ltd. performanceFree Breakout Entry Signal Confirmation Tool - Newser
Class Action Filed Against Biohaven Ltd. (BHVN) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biohaven Ltd.(BHVN) Shareholders - GlobeNewswire
Shareholders that lost money on Biohaven Ltd.(BHVN) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - Morningstar
Exit strategy if you’re trapped in Biohaven Ltd.High Probability Trade Plan with Indicators - Newser
How to interpret RSI for Biohaven Ltd. stockFree Daily Volume Spike Trading Signals - Newser
BHVN LAWSUIT ALERT: Levi & Korsinsky Notifies Biohaven Ltd. InvestorsLead Plaintiff Deadline September 12, 2025 - ACCESS Newswire
Biohaven Ltd. Sued for Securities Law ViolationsContact The Gross Law Firm Before September 12, 2025 to Discuss Your RightsBHVN - Barchart.com
Biohaven (BHVN) to Release Quarterly Earnings on Thursday - Defense World
Biohaven Ltd. (NYSE:BHVN) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Finanzdaten der Biohaven Ltd-Aktie (BHVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):